Published in Contraception on October 27, 2006
Depot Medroxyprogesterone Acetate as Emergency Contraception | NCT03395756
As the world grows: contraception in the 21st century. J Clin Invest (2008) 1.37
Emergency contraception: potential role of ulipristal acetate. Int J Womens Health (2010) 1.08
Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol (2010) 0.96
Contraceptive Use and the Risk of Ectopic Pregnancy: A Multi-Center Case-Control Study. PLoS One (2014) 0.82
Levonorgestrel in cases of rape: How does it work? Linacre Q (2014) 0.78
Mechanism of action of levonorgestrel emergency contraception. Linacre Q (2015) 0.77
Emergency contraception. Paediatr Child Health (2010) 0.76
Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol (2014) 0.75
A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception. BMC Womens Health (2014) 0.75
A tiered analytical approach for investigating poor quality emergency contraceptives. PLoS One (2014) 0.75
Appreciation for analysis of how levonorgestrel works and reservations with the use of meloxicam as emergency contraception. Linacre Q (2016) 0.75
Does levonorgestrel emergency contraceptive have a post-fertilization effect? A review of its mechanism of action. Linacre Q (2016) 0.75
Effectiveness of levonorgestrel given after or before ovulation. Contraception (2008) 0.75
"I don't know what I would have done." Women's experiences acquiring ulipristal acetate emergency contraception online from 2011 to 2015. Contraception (2016) 0.75
UPA > LNG, but Not Good Enough. Contraception (2013) 0.75
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Age-related testosterone depletion and the development of Alzheimer disease. JAMA (2004) 2.45
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44
Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril (2004) 2.33
FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet (2011) 2.29
Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol (2002) 2.27
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) (2006) 2.17
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care (2008) 2.05
Mechanisms of abnormal uterine bleeding. Hum Reprod Update (2002) 2.05
Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care (2008) 2.04
Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol (2010) 2.00
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception (2010) 1.96
Comparison of three single doses of mifepristone as emergency contraception: a randomised controlled trial. Aust N Z J Obstet Gynaecol (2005) 1.93
Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception (2011) 1.89
Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer (2012) 1.82
Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab (2006) 1.76
Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecol (2011) 1.74
Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab (2007) 1.66
Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol (2012) 1.66
Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis (2008) 1.63
Insulin resistance and prostate cancer risk. J Natl Cancer Inst (2003) 1.61
Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception (2010) 1.59
Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol (2011) 1.56
Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2006) 1.56
Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev (2007) 1.53
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception (2009) 1.52
Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab (2010) 1.46
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause (2014) 1.46
Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol (2006) 1.46
Endometrial thickness measured by ultrasound scan in women with uterine outlet obstruction due to intrauterine or upper cervical adhesions. Hum Reprod (2007) 1.45
Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril (2012) 1.45
Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab (2007) 1.44
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate (2003) 1.40
Reliability of extraction/chromatography RIAs. Clin Chem (2004) 1.40
Missed contraceptive pills and the critical pill-free interval. Lancet (2005) 1.39
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab (2007) 1.38
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.35
Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins. Contraception (2008) 1.34
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.34
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 1.30
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.29
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci U S A (2012) 1.26
Hormones and prostate cancer: current perspectives and future directions. Prostate (2002) 1.26
Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2005) 1.26
Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.24
Nerve fibres in peritoneal endometriosis. Hum Reprod (2006) 1.23
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol (2010) 1.23
Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception (2009) 1.16
Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging (2009) 1.14
Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiol Biomarkers Prev (2008) 1.14
Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril (2002) 1.13
Predictors of noncompliance in an oral contraceptive clinical trial. Contraception (2011) 1.13
Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev (2012) 1.12
Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis (2005) 1.12
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin Cancer Res (2006) 1.10
Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Menopause (2009) 1.10
The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care (2008) 1.10
A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Menopause (2008) 1.10
Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast (2005) 1.10
Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr (2009) 1.10
No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2005) 1.09
Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception (2007) 1.08
Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review. Contraception (2010) 1.08
Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res (2010) 1.08
Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev (2005) 1.06
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev (2011) 1.06
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception (2005) 1.06
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res (2004) 1.05
A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr (2005) 1.05
Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res (2004) 1.05
Rich innervation of deep infiltrating endometriosis. Hum Reprod (2009) 1.05
Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception (2013) 1.05
Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. J Natl Cancer Inst (2009) 1.04
Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer (2010) 1.04
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception (2012) 1.04
Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. BMJ (2010) 1.03
The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril (2011) 1.03
Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril (2007) 1.02
Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab (2011) 1.02
Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) (2012) 1.02
Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res (2009) 1.01
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat (2007) 1.01
Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer (2011) 1.01
Decreased endopelvic fascia elastin content in uterine prolapse. Acta Obstet Gynecol Scand (2008) 0.99
Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer (2007) 0.99
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control (2011) 0.98
Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Menopause (2015) 0.98
The role of Foxp3+ regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum Reprod (2010) 0.98
Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate (2002) 0.98
Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control (2009) 0.98
Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer (2011) 0.98
Impaired dihydrotestosterone catabolism in human prostate cancer: critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling. Cancer Res (2007) 0.97